Hypertension - A US Perspective on the World's Biggest Pharmaceutical Market

Author：

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.12, Iss.2, 2003-02, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Market share biggest influencer on generic pricing in EU

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 638, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Selfish DNA: a pharmaceutical perspective

By Winckler T.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 467-473

Govi-Verlag

Access to resources Recommend Favorite

Nebivolol: In the Treatment of Hypertension in the US

By Baldwin Claudine M. Keam Susan J.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Over the next 3 years, the combined pharmaceutical market of the eight countries to join the EU in 2004 could increase by 50% to $US14 billion

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Hypertension in the Elderly: A Japanese Perspective

By Ogihara Toshio Rakugi Hiromi

Drugs & Aging, Vol. 22, Iss. 4, 2005-01 ,pp. : 297-314

Adis International

Access to resources Recommend Favorite